Cefpodoxime: Difference between revisions

Revision as of 13:32, 15 January 2014

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Abdurahman Khalil, M.D. [2]

Cefpodoxime (marketed as the prodrug cefpodoxime proxetil by Pharmacia & Upjohn under the trade name Vantin®) is an oral third generation cephalosporin antibiotic. It is active against most Gram positive and Gram negative bacteria. Notable exceptions include Pseudomonas aeruginosa, Enterococcus, and Bacteroides fragilis. It is commonly used to treat acute otitis media, pharyngitis, and sinusitis. It also finds use as oral continuation therapy when intravenous cephalosporins (such as ceftriaxone) are no longer necessary for continued treatment. Pfizer, the parent company of Pharmacia & Upjohn, markets Cefpodoxime proxetil under the trade name Simplicef® for veterinary use. The dose range in dogs is 5-10 mg/kg body weight, administered orally, once a day. Outside the US, Cefpodoxime proxetil is marketed as Banan®.

VANTIN^®

@@ Line 25: / Line 25: @@
 '''| [[Cefpodoxime clinical studies|Clinical Studies]]'''
 '''| [[Cefpodoxime dosage and administration|Dosage and Administration]]'''
-'''| [[Cefpodoxime compatibility reconstitution and stability|Compatibility, Reconstitution, and Stability]]'''
-'''| [[Cefpodoxime directions for use|Directions For Use]]'''
 '''| [[Cefpodoxime how supplied|How Supplied]]'''
 '''| [[Cefpodoxime labels and packages|Labels and Packages]]'''
 ==References==